PRESS RELEASE: Sign Up for a Complimentary Trial of Inside Health Policy - No Obligation, Expires Automatically

PRESS RELEASE
Contact: Steve Reilly
Phone: (703)-562-8992
Email: sreilly@iwpnews.com
Website: www.InsideHealthPolicy.com

WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- DECEMBER 6, 2021: The Biden administration's legislative agenda is hitting high gear with the House approval of social spending and climate bills. If passed in the Senate in the coming weeks, these bills will have far-reaching impacts on drug pricing, medicare, and much more. Combined with the continuing struggle with COVID-19, the end of 2021 and into 2022 is set to be a busy time for health policy.

Sign up for a free trial subscription to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers.

Here is a sample of the latest Inside Health Policy stories that you can read with your free trial:

FDA Panel Grapples With Safety Concerns Over Merck's COVID Pill
FDA advisers on Tuesday (Nov. 30) narrowly voted 13 to 10 in favor of authorizing Merck's COVID-19 pill molnupiravir to treat mild-to-moderate COVID-19 in people 18 and up, with many calling for restrictions on who can get the drug in order to limit its safety risks to unborn children and to stem the potential creation of new variants when given to immunocompromised patients.

Senior Aide: Dems Looking To Avoid Medicare Sequester Cuts Before 2022
Congressional Democrats are exploring avenues to avert Medicare sequester cuts before the end of the year, a senior Democratic aide told Inside Health Policy Tuesday (Nov. 30), coming as hospitals step up lobbying to get lawmakers to avert the payment reductions slated to kick in Jan. 1.

SCOTUS Justices Ask Hard Questions Of Both Sides In 340B Case
Supreme Court justices on Tuesday (Nov. 30) posed tough questions to both sides in a lawsuit over Medicare reimbursement of 340B drugs that could have impacts beyond hospital drug reimbursement.

SCOTUS Hears Arguments Over Medicare DSH Payments
The Supreme Court case over whether CMS can exclude patients who have exhausted their Medicare Part A benefits from hospitals' disproportionate share payments evolved during Monday's (Nov. 29) oral arguments into a debate over the difference between beneficiaries who are entitled to Medicare benefits versus those who are eligible for them.

LA Judge Puts CMS' COVID-19 Mandate On Hold Nationwide As Admin Appeals MO Judge's Order
A Louisiana federal district court judge on Tuesday (Nov. 30) temporarily halted CMS' COVID-19 vaccine requirement for health care workers nationwide until a lawsuit from 14 states over the rule has been dealt with. The decision came the same day that the federal government appealed a Missouri district court judge's separate move to block the rule in 10 states while a lawsuit is ongoing, saying the court should keep the mandate in place until a higher court hears its appeal.

You can try Inside Health Policy for the next month with absolutely no obligation, your trial will simply expire at the end of 30 days. . Your trial includes online access to the newsletter you choose: Inside CMS, FDA Week, Health Exchange Alert, or Inside Drug Pricing - and please call us if you want access to a second newsletter with your trial. Plus, if you choose to subscribe, we'll offer you 50% off for the first year of access.